Edwards J L, Hughey T C, Moore A B, Cox N M
Department of Animal and Dairy Sciences, Mississippi State University, Mississippi 39762, USA.
Biol Reprod. 1996 Oct;55(4):775-81. doi: 10.1095/biolreprod55.4.775.
The objectives were to investigate whether insulin-dependent diabetes mellitus disrupts production of estradiol and activity of the insulin-like growth factor (IGF)-I system in individual ovarian follicles during the preovulatory period of the estrous cycle. Diabetes mellitus was induced with streptozocin (150 mg/kg) in seven cyclic gilts at 180 +/- 5 days of age. On Day 12 of the estrous cycle, insulin replacement therapy was withdrawn from three gilts and continued in four; four gilts served as normal controls. After ovary removal on Day 18, all follicles > or = 3 mm diameter were dissected free and cultured for 6 h in the presence of 280 ng testosterone for assessment of estradiol and IGF-I production and binding protein activity. Treatments did not affect corpora lutea number (15.4 +/- 0.8) or serum estradiol (5.8 +/- 0.8 pg/ml) on Day 18. There were no differences for any measure of follicular development between normal and insulin-treated diabetic gilts. Untreated diabetic gilts, compared to normal and insulin-treated diabetic gilts, had fewer total visible follicles (22.7 vs. 61.3 and 63.3; SEM = 8; p < 0.01) and reduced follicular diameter (3.4 vs. 4.4 and 4.2 mm; SEM = 0.3; p < 0.0001), respectively. Untreated diabetic gilts had a greater percentage of macroscopically atretic follicles than normal and insulin-treated diabetic gilts (75% vs. 47% and 36%; SEM = 10; p < 0.05). Untreated diabetes mellitus lowered estradiol (p < 0.01); however, effects of treatment on estradiol production were not significant when diameter was part of statistical models. When contents of IGF-I in follicular fluid and conditioned medium were summed after 6 h of culture, untreated diabetic pigs had lower IGF-I at all follicle diameters than pigs in the other treatments (p < 0.05). IGF binding protein (BP) activity was affected by diabetes mellitus, with untreated diabetic pigs having greater IGFBP-1 activity in medium and with both diabetic groups having greater IGFBP-2 activity in follicular fluid (p < 0.05). Activity of IGFBP-1 predominated in conditioned medium, and IGFBP-2 activity predominated in follicular fluid. IGFBP-3 was decreased in follicular fluid of atretic follicles and in medium of atretic follicles in all except the insulin-treated diabetic gilts; in these gilts it was increased in atretic follicles (treatment by atresia interaction; p < 0.05). In conclusion, estradiol was most related to size of the follicle; however, lowering of IGF-I regardless of follicle diameter and alterations in IGFBP activity suggest that diabetes affects IGF-I and its binding proteins differently from estradiol production. These alterations may explain reduced follicular growth and increased follicular atresia in diabetic pigs.
本研究旨在探讨胰岛素依赖型糖尿病是否会在发情周期的排卵前期干扰单个卵巢卵泡中雌二醇的产生以及胰岛素样生长因子(IGF)-I系统的活性。在180±5日龄的7头周期性后备母猪中,用链脲佐菌素(150mg/kg)诱导糖尿病。在发情周期的第12天,停止对3头后备母猪进行胰岛素替代治疗,另外4头继续治疗;4头后备母猪作为正常对照。在第18天切除卵巢后,将所有直径≥3mm的卵泡分离出来,在存在280ng睾酮的情况下培养6小时,以评估雌二醇和IGF-I的产生以及结合蛋白活性。治疗对第18天的黄体数量(15.4±0.8)或血清雌二醇(5.8±0.8pg/ml)没有影响。正常和胰岛素治疗的糖尿病后备母猪在卵泡发育的任何指标上均无差异。与正常和胰岛素治疗的糖尿病后备母猪相比,未治疗的糖尿病后备母猪可见卵泡总数较少(分别为22.7个对61.3个和63.3个;标准误=8;p<0.01),卵泡直径减小(分别为3.4mm对4.4mm和4.2mm;标准误=0.3;p<0.0001)。未治疗的糖尿病后备母猪肉眼可见的闭锁卵泡百分比高于正常和胰岛素治疗的糖尿病后备母猪(分别为75%对47%和36%;标准误=10;p<0.05)。未治疗的糖尿病降低了雌二醇水平(p<0.01);然而,当直径作为统计模型的一部分时,治疗对雌二醇产生的影响并不显著。培养6小时后,将卵泡液和条件培养基中的IGF-I含量相加,未治疗的糖尿病猪在所有卵泡直径下的IGF-I水平均低于其他治疗组的猪(p<0.05)。IGF结合蛋白(BP)活性受糖尿病影响,未治疗的糖尿病猪培养基中的IGFBP-1活性较高,两个糖尿病组卵泡液中的IGFBP-2活性均较高(p<0.05)。条件培养基中IGFBP-1活性占主导,卵泡液中IGFBP-2活性占主导。除胰岛素治疗的糖尿病后备母猪外,闭锁卵泡的卵泡液和闭锁卵泡的培养基中IGFBP-3均降低;在这些后备母猪中,闭锁卵泡中的IGFBP-3增加(治疗与闭锁的相互作用;p<0.05)。总之,雌二醇与卵泡大小最相关;然而,无论卵泡直径如何,IGF-I水平降低以及IGFBP活性改变表明糖尿病对IGF-I及其结合蛋白的影响与雌二醇产生不同。这些改变可能解释了糖尿病猪卵泡生长减少和卵泡闭锁增加的原因。